Good Manufacturing Practices (GMP) – Page 4

Poor change control discipline during internal audit – CAPA framework to prevent recurrence

Identifying symptoms of poor change control is crucial in a fast-paced pharmaceutical environment. These signals can manifest both physically on the production floor and through data deviations in laboratories. Below…

Batch documentation gaps during technology transfer – how to rebuild GMP maturity

Recognizing the symptoms associated with batch documentation gaps is the first step towards remediation. Common signals that may indicate inadequacies during technology transfer include:Click to read the full article.

Repeated GMP deviations during internal audit – FDA/EMA inspection citation risk

Recognizing the signals indicative of potential GMP deviations is fundamental to addressing compliance issues. Symptoms can manifest in various forms:Click to read the full article.

Repeated GMP deviations during internal audit – FDA/EMA inspection citation risk

Recognizing symptoms of GMP deviations is critical for timely intervention. The following are indicative signals that could suggest underlying compliance issues:Click to read the full article.

Inconsistent GMP interpretation during technology transfer – CAPA framework to prevent recurrence

Identifying the symptoms of inconsistent GMP interpretations is crucial for timely intervention. Common signals include:Click to read the full article.

Weak management oversight during regulatory inspection – root cause analysis inspectors expect

During inspections, certain signals may indicate weak management oversight. Understanding and recognizing these symptoms early can guide professionals in addressing fundamental issues before they escalate.Click to read the full article.

Uncontrolled SOP changes during regulatory inspection – how to rebuild GMP maturity

Detecting the early signs of uncontrolled SOP changes is crucial in maintaining compliance. Some key symptoms include:Click to read the full article.

Inadequate GMP training during internal audit – root cause analysis inspectors expect

Identifying signals of inadequate GMP training is critical to maintaining compliance and quality. Here are some common symptoms you may observe:Click to read the full article.

Repeated GMP deviations during regulatory inspection – evidence package for inspection defense

Identifying symptoms early on can provide a crucial advantage in addressing GMP deviations. Common signals include:Click to read the full article.

Uncontrolled SOP changes during routine manufacturing – FDA/EMA inspection citation risk

Identifying symptoms of uncontrolled SOP changes is the first step in managing them effectively. Symptoms can manifest in various ways across the manufacturing environment:Click to read the full article.

Batch documentation gaps during routine manufacturing – how to rebuild GMP maturity

Identifying batch documentation gaps starts with recognizing specific symptoms or signals that surface during routine manufacturing processes. Here are common indicators:Click to read the full article.

Poor change control discipline during technology transfer – root cause analysis inspectors expect

Identifying symptoms of poor change control is the first step in addressing the issue. Common signals may include:Click to read the full article.